备受资本市场关注的*ST长药（300391）（300391.SZ）重整事宜，迎来新进展。5月8日，*ST长药发布 公告称，2025年5月6日，公司和临时管理人分别与产业投资人四川嘉道博文生态科技有限公司等六家机 构签署重整投资协议。 *ST长药方面表示，若公司预重整及重整程序得以顺利推进并重整成功，将有利于改善公司的财务结 构、化解债务。在引入重整投资人后，公司可获得增量资金，有利于恢复和增强公司的持续经营能力。 六家机构携手投资入局 2025年1月20日，*ST长药收到湖北省十堰市中级人民法院（下称"十堰中院"）送达的《决定书》，十 堰中院决定对公司启动预重整，并指定上海市锦天城律师事务所担任公司预重整期间的临时管理人。 公告披露，经*ST长药临时管理人组织召开遴选委员会会议，由遴选委员会对意向投资人提交的重整投 资方案进行评审，最终投票确定了磋商谈判重整投资协议的顺位。经与排序优先的候选投资人进行磋商 后，2025年5月6日，公司和临时管理人分别与产业投资人四川嘉道博文生态科技有限公司、十堰市昊炜 生物科技发展有限公司，财务投资人合肥当歌长弘创业投资合伙企业(有限合伙)、安徽宏业股权投资基 金有限公司、上 ...

Summary of Key Points Core Viewpoint - Ningbo Shanshan Co., Ltd. announced the provision of guarantees for its subsidiaries to support their financing needs, with a total guarantee amount of 36 million RMB, while the total guarantees provided by the company and its subsidiaries exceed 525.5 million RMB [2][5]. Group 1: Guarantee Details - The guarantee amount for Shanghai Shanshan New Materials Co., Ltd. is up to 13 million RMB, for Yunnan Shanshan New Materials Co., Ltd. is up to 18 million RMB, and for Fujian Shanshan Technology Co., Ltd. is up to 5 million RMB [5]. - The total external guarantees provided by the company and its subsidiaries as of March 31, 2025, amount to 1,864.79 million RMB, which is 86.41% of the latest audited net assets attributable to shareholders [12]. Group 2: Internal Decision-Making Process - The board of directors approved the guarantee provision at the annual shareholders' meeting held on May 16, 2024, authorizing the chairman to sign specific guarantee documents within the approved limits [6][11]. Group 3: Financial Condition of Guaranteed Entities - The asset-liability ratio of the guaranteed entity, Shanghai Shanshan New Materials Co., Ltd., exceeds 70%, indicating a high level of financial leverage [4]. - The registered capital of Shanghai Shanshan New Materials Co., Ltd. is 100 million RMB, while Yunnan Shanshan New Materials Co., Ltd. has a registered capital of 205 million RMB, and Fujian Shanshan Technology Co., Ltd. has a registered capital of 20 million RMB [7][8]. Group 4: Impact of Shareholder Restructuring - The controlling shareholder, Shanshan Group, is undergoing a substantial merger restructuring, with creditors required to declare their claims by April 30, 2025 [13][14]. - The restructuring may lead to adjustments in shareholder equity, potentially affecting the company's control [16].

ST华闻（000793）公告，公司于2025年5月6日与海南联合资产管理有限公司和海南省国有资本运营有 限公司签署了重整投资协议。根据协议，两家产业投资人合计支付6.1亿元重整投资款，受让公司转增 股份5亿股，每股价格为1.22元。重整投资旨在恢复和改善公司持续经营能力。海南联合、海南国资运 营作为预重整产业投资人，承诺在华闻集团重整计划获得海南省海口市中级人民法院裁定批准后，全面 履行投资义务。临时管理人已收到海南联合支付的报名保证金3000万元，将在投资款支付时转化为等额 投资款。 ...

Group 1: Financial Performance - The company's photovoltaic revenue decreased by over 60% year-on-year, primarily due to the impact of restructuring [3] - Fixed asset and inventory impairment provisions amount to approximately 800 million, raising concerns about further impairment risks [5] - The revenue share from the top five customers increased year-on-year, indicating a focus on maintaining key client relationships [5] Group 2: Restructuring and Investment - The company is currently in a restructuring phase, with all funds from participating investors fully in place [2] - The restructuring plan was completed by the end of 2024, with a focus on restoring production capacity [2] - There is no confirmed strategic investor with clear funding intentions at this time [2] Group 3: Market Strategy and Operations - The company plans to continue its dual-core business strategy of "photovoltaics + cables," despite the challenges faced in the photovoltaic sector [3] - There is no substantial impact on overseas business from the European anti-dumping investigation on Chinese photovoltaic products [2] - The company is actively optimizing its product structure and market layout to enhance competitiveness and risk resistance [2] Group 4: Future Outlook - Future growth drivers include the empowerment from new controlling shareholders and a focus on global R&D and service capabilities [3] - The company has not yet entered the production of ultra-high voltage cables but is monitoring opportunities in smart grid renovation orders [4]

Core Viewpoint - In April 2025, Hunan Jingfeng Pharmaceutical Co., Ltd. released its 2024 annual report, revealing significant changes in key financial indicators such as revenue, net profit, and cash flow, indicating potential operational challenges and risks for investors [1] Financial Performance Summary - **Revenue**: The company reported a revenue of 416,031,777.19 yuan in 2024, a decrease of 36.67% from 656,893,837.84 yuan in 2023. The pharmaceutical business accounted for 94.05% of total revenue, declining by 37.86% [2] - **Net Profit**: The net profit attributable to shareholders was 152,304,308.31 yuan, a turnaround from a loss of 236,100,444.69 yuan in 2023. However, the net profit excluding non-recurring items was -76,117,930.25 yuan, indicating weak core business profitability [3] - **Earnings Per Share**: Basic earnings per share improved to 0.1731 yuan from -0.2684 yuan in 2023, while the diluted earnings per share excluding non-recurring items was -0.0865 yuan, highlighting the disparity in earnings quality [4] Expense Analysis - **Sales Expenses**: Sales expenses decreased by 60.51% to 137,032,632.93 yuan from 347,051,196.83 yuan in 2023, potentially impacting market promotion and sales performance [5] - **Management Expenses**: Management expenses fell by 28.09% to 112,695,669.98 yuan, reflecting successful cost reduction measures [6] - **Financial Expenses**: Financial expenses remained stable at 40,282,025.19 yuan, indicating ongoing debt pressure, with a notable bond balance of 185 million yuan due [7] Cash Flow Analysis - **Operating Cash Flow**: The net cash flow from operating activities turned negative at -5,550,958.03 yuan, down 115.83% from 35,063,943.44 yuan in 2023, indicating weakened cash generation ability [10] - **Investing Cash Flow**: The net cash flow from investing activities was positive at 64,489,461.03 yuan, a recovery from -9,366,822.30 yuan in 2023, primarily due to asset disposals [11] - **Financing Cash Flow**: The net cash flow from financing activities improved to -10,724,112.52 yuan from -192,978,032.40 yuan in 2023, reflecting a need for improved financing conditions [12] Overall Assessment - Despite achieving a net profit turnaround, the company faces challenges with declining revenue, deteriorating cash flow, and reduced R&D investment, which may impact future growth potential. Investors should closely monitor the company's restructuring process, market strategy adjustments, and cost control efforts to assess investment value and risks [1]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002217 证券简称：*ST合泰 公告编号：2025-038 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、 误导性陈述或重大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息 的真实、准确、完整。 3.第一季度报告是否经审计 □是 √否 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 √否 ■ （二） 非经常性损益项目和金额 将《公开发行证券的公司信息披露解释性公告第1号一一非经常性损益》中列举的非经常性损益项目界 定为经常性损益项目的情况说明 □适用 √不适用 公司不存在将《公开发行证券的公司信息披露解释性公告第1号一一非经常性损益》中列举的非经常性 损益项目界定为经常性损益的项目的情形。 （三） 主要会计数据和财务指标发生变动的情况及原因 √适用 □不适用 ...

Core Viewpoint - Wuxi East Heavy Machinery Co., Ltd. announced that its subsidiaries, Wuxi East Photovoltaic Technology Co., Ltd. and East Photovoltaic Technology (Xuzhou) Co., Ltd., have been accepted for reorganization by the courts due to their inability to repay debts, with the aim of restoring normal operations and improving debt repayment capabilities [2][4][10]. Group 1: Reorganization Details - The reorganization applications for Wuxi East Photovoltaic and Xuzhou Photovoltaic were filed by creditor Zhejiang Kaiying New Materials Co., Ltd. due to the subsidiaries' inability to repay due debts [2][4]. - The courts have accepted the reorganization applications, indicating that both subsidiaries have potential for recovery and can better repay debts through this process [10][11]. - The reorganization process aims to optimize the debt structure of the subsidiaries and mitigate risks while protecting the rights of small investors [3][11]. Group 2: Financial Impact - In 2024, the photovoltaic business generated revenue of 295.5744 million yuan, accounting for 24.96% of the company's total revenue [3][28]. - The company has provided financial support of 380 million yuan to Xuzhou Photovoltaic and 27 million yuan to Wuxi Photovoltaic, making it a significant creditor [12][11]. - The reorganization may impact the company's ability to recover financial support provided to the subsidiaries [12][11]. Group 3: Subsidiary Information - Wuxi East Photovoltaic was established on April 17, 2023, with a registered capital of 200 million yuan, while Xuzhou Photovoltaic was established on April 19, 2023, with a registered capital of 500 million yuan [7][9]. - Wuxi East Photovoltaic reported total assets of 184.7102 million yuan and a net loss of 1.2976 million yuan for the year ending December 31, 2024 [7]. - Xuzhou Photovoltaic reported total assets of 702.4191 million yuan, total liabilities of 800.0794 million yuan, and a net loss of 183.7302 million yuan for the same period [9]. Group 4: Legal Proceedings - The courts have recognized the jurisdiction over the reorganization cases based on the location of the subsidiaries and the established debts owed to the creditor [10][11]. - The reorganization is distinct from bankruptcy liquidation, focusing on saving the companies and restoring their profitability [11][10]. - The company will cooperate with the courts and management to explore feasible reorganization strategies, including potential investments from industry players [11][12].

登录新浪财经APP 搜索【信披】查看更多考评等级 公司是否需追溯调整或重述以前年度会计数据 证券代码：002124 证券简称：ST天邦 公告编号：2025-036 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、 误导性陈述或重大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息 的真实、准确、完整。 3.第一季度报告是否经审计 □是 √否 一、主要财务数据 （一） 主要会计数据和财务指标 □是 √否 ■ （二） 非经常性损益项目和金额 √适用 □不适用 单位：元 ■ 其他符合非经常性损益定义的损益项目的具体情况 □适用 √不适用 公司不存在其他符合非经常性损益定义的损益项目的具体情况。 将《公开发行证券的公司信息披露解释性公告第1号一一非经常性损益》中列举的非经常性损益项目界 定为经常性损益项目的情况说明 □适用 √不适用 公司不存在将《公开发行证券的公司信息披露解释性公告 ...

Core Viewpoint - King Kong Photovoltaic (300093.SZ) announced that its wholly-owned subsidiaries or subsidiaries, including King Kong Yide, Ouhao Power, Suzhou Profile, and Suzhou King Kong, have applied to the court for reorganization due to their inability to repay due debts and a clear lack of repayment capacity [1] Group 1 - The reorganization aims to coordinate debt repayment resources, ensure work efficiency, and resolve the debt crisis while protecting creditor interests [1] - The matter is subject to approval by the company's shareholders' meeting [1]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002124 证券简称：ST天邦 公告编号：2025-031 天邦食品股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 一、本期业绩预计情况 1、业绩预告期间：2025年1月1日至2025年3月31日 2、业绩预计： 2025年一季度预计业绩情况 □亏损 □扭亏为盈 □同向上升 √同向下降 2025年一季度业绩预告 二、业绩预告预审计情况 本次业绩预告未经会计师事务所预审计。 三、业绩变动原因说明 ■ 1、本次业绩预告是公司财务部门的初步估算结果，具体财务数据公司将在2025年一季度报告中详细披 露。 2、商品猪市场价格的大幅波动（下降或上升）、非洲猪瘟等疫病风险都可能会对公司的经营业绩产生 重大影响，敬请广大投资者谨慎决策，注意投资风险。 根据《股票上市规则》第9.4.1条的相关规定，如法院依法裁定受理公司重整申请，公司股票将在重整申 请受理后被实施退市风险警示（*ST）。 3、公司股票可能存在终止上市的风险 如法院正式受理公司的重整申请，公司可能存在因重整失败而被宣告破产的风险。如果公 ...